Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey

Published:2023-11-15 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Augustin Matthias¹,Nosbaum Audrey²,Werfel Thomas³,Grond Susanne⁴,Reed Catherine⁴,Lampropoulou Anastasia⁴,Tietz Nicole⁴,Irvine Alan D.⁵,Riedl Elisabeth⁶

Affiliation:

1. Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

2. Department of Allergy and Clinical Immunology, Hospices Civils de Lyon, Centre Hospitalier, Lyon Sud, France

3. Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany

4. Eli Lilly and Company Ltd, Indianapolis, IN, USA

5. Dermatology Clinic, Our Lady’s Children’s Hospital Crumlin, Dublin, Ireland

6. Department of Dermatology, Medical University of Vienna, Vienna, Austria

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2276047

Reference24 articles.

1. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

2. Microbiome in the Gut-Skin Axis in Atopic Dermatitis

3. Guidelines of care for the management of atopic dermatitis

4. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*

5. Itch in Atopic Dermatitis – What Is New?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch;Dermatology and Therapy;2024-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3